期刊
DALTON TRANSACTIONS
卷 47, 期 2, 页码 507-516出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c7dt03613b
关键词
-
资金
- Dutch Organisation for Scientific Research (NWO-CW) via a VIDI grant
- European Research Council
Three new trans-ruthenium(II) complexes coordinated to tetrapyridyl ligands, namely [Ru(bapbpy)(dmso) Cl] Cl ([2] Cl), [Ru(bapbpy)(Hmte) 2](PF6)(2) ([3](PF6)(2)), and [Ru(biqbpy)(Hmte)(2)](PF6)(2) ([4](PF6)(2)), were prepared as analogues of [Ru(biqbpy)(dmso) Cl] Cl ([1] Cl), a recently described photoactivated chemotherapy agent. The new complexes were characterized, and their crystal structures showed the distorted coordination octahedron typical of this family of complexes. Their photoreactivity in solution was analyzed by spectrophotometry and mass spectrometry, which showed that the sulfur ligand was substituted upon blue light irradiation. The binding of the ruthenium complexes to a reference single-stranded oligonucleotide (s(5' CTACGGTTTCAC3')) was explored both in the dark and under light irradiation by gel electrophoresis and high-resolution mass spectrometry. While adduct formation in the dark was negligible for the four complexes, light irradiation led to the formation of adducts with one or two ruthenium centers per oligonucleotide. The absence of interactions in the dark and the presence of complex-oligonucleotide adducts demonstrate that visible light controls the interaction of these ruthenium complexes with nucleic acids.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据